In this review of dermatology news in April, we highlighted several major stories on such topics as cutaneous reactions to COVID-19, topical versus oral minoxidil, and FDA news.
1. Progression-free survival was longer in the lazertinib group vs the gefitinib group (20.6 months vs 9.7 months, with HR 0.45), however, OS data were immature. 2. Treatment-related adverse events were similar across both groups, however, lazertinib had higher rates of parasthesia and pruritus but lower levels of ALT elevations and diarrhea. Evidence Rating Level:
Messerattacke in Würzburg: Wie der 24-Jährige nach Deutschland kam und wie er vor der Tat auffällig wurde infranken.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infranken.de Daily Mail and Mail on Sunday newspapers.